Literature DB >> 27504474

Role of dual energy spectral computed tomography in characterization of hepatocellular carcinoma: Initial experience from a tertiary liver care institute.

S T Laroia1, Ajeet Singh Bhadoria2, Yamini Venigalla1, G K Chibber3, Chagan Bihari4, Archana Rastogi4, S K Sarin5.   

Abstract

OBJECTIVE: To investigate dual-energy spectral CT in characterization of hepatocellular Carcinoma (HCC) in patients with chronic liver disease.
METHODS: Dynamic computed tomography (CT) was performed in 3600 patients (2879 males; 721 females, mean age 50.9 ± 11.9 years) with working clinical diagnosis of liver cirrhosis for hepatocellular carcinoma screening and other clinical indications. The study was conducted over a period of 3 years. During dynamic CT scanning, spectral (monochromatic) and routine (polychromatic) CT acquisitions were obtained on a single tube, dual energy, 64 slice multi-detector CT scanner. Imaging findings were studied on routine CT. On the basis of routine CT findings, indeterminate lesions (lesions not showing characteristic hypervascularity followed by washout on dynamic routine CT scan) that were referred for biopsy or surgery were segregated. A retrospective blinded review of the lesions, acquired by the spectral CT acquisitions was done with the help of gem stone imaging (GSI) software to characterize these lesions. All the above lesions were analyzed qualitatively in the arterial phase for lesion conspicuity as well as quantitatively using the monochromatic data sets and nodule Iodine concentration on material density maps, respectively. This data was studied with respect to predictability of HCC using the spectral CT technique. Iodine density of the lesion, surrounding liver parenchyma, and lesion to liver parenchyma ratio (LLR) were derived and statistically analyzed. Histopathology of the lesion in question was treated as gold standard for analysis.
RESULTS: It was observed via statistical analysis that the value of iodine density of the lesion on material density sets of ≥29.5 mg/dl, enabled a discriminatory power of 86.5%, sensitivity of 90.5% with 95% confidence Interval (CI) (69.2-98.8%) and specificity of 81.2% with 95% Confidence Interval (54.4-95.9%) in predicting HCC. Qualitative assessment also showed higher lesion conspicuity with spectral CT image sets as compared to routine CT data.
CONCLUSION: This study reveals that spectral imaging is an excellent qualitative as well as a quantitative tool for assessing and predicting hepatocellular carcinoma in cirrhotic patients.

Entities:  

Keywords:  CI, confidence interval; CT, computed tomography; DECT, dual energy computed tomography; Dual energy computed tomography; Functional imaging; GSI, gem stone imaging; HCC, hepatocellular carcinoma; Hepatocellular carcinoma; Iodine quantification; LLR, lesion to liver parenchyma ratio; MMD, monochromatic material density; Material density images; Spectral computed tomography

Year:  2016        PMID: 27504474      PMCID: PMC4968142          DOI: 10.1016/j.ejro.2016.05.007

Source DB:  PubMed          Journal:  Eur J Radiol Open        ISSN: 2352-0477


  32 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging?

Authors:  Courtney A Coursey; Rendon C Nelson; Daniel T Boll; Erik K Paulson; Lisa M Ho; Amy M Neville; Daniele Marin; Rajan T Gupta; Sebastian T Schindera
Journal:  Radiographics       Date:  2010 Jul-Aug       Impact factor: 5.333

Review 3.  Dual energy CT: preliminary observations and potential clinical applications in the abdomen.

Authors:  Anno Graser; Thorsten R C Johnson; Hersh Chandarana; Michael Macari
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315

4.  Additional value of dual-energy CT to differentiate between benign and malignant mediastinal tumors: an initial experience.

Authors:  Seung Hyun Lee; Jin Hur; Young Jin Kim; Hye-Jeong Lee; Yoo Jin Hong; Byoung Wook Choi
Journal:  Eur J Radiol       Date:  2013-06-29       Impact factor: 3.528

5.  Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies.

Authors:  Kyung Su Kim; Jeong Min Lee; Seung Ho Kim; Kyung Won Kim; Soo Jin Kim; Seung Hyun Cho; Joon Koo Han; Byung Ihn Choi
Journal:  Invest Radiol       Date:  2010-03       Impact factor: 6.016

6.  Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

Authors:  Masatoshi Kudo; Namiki Izumi; Norihiro Kokudo; Osamu Matsui; Michiie Sakamoto; Osamu Nakashima; Masamichi Kojiro; Masatoshi Makuuchi
Journal:  Dig Dis       Date:  2011-08-09       Impact factor: 2.404

7.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

Authors:  H Tsukuma; T Hiyama; S Tanaka; M Nakao; T Yabuuchi; T Kitamura; K Nakanishi; I Fujimoto; A Inoue; H Yamazaki
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

8.  Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

Authors:  C Niederau; S Lange; T Heintges; A Erhardt; M Buschkamp; D Hürter; M Nawrocki; L Kruska; F Hensel; W Petry; D Häussinger
Journal:  Hepatology       Date:  1998-12       Impact factor: 17.425

9.  Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Authors:  Alejandro Forner; Ramón Vilana; Carmen Ayuso; Lluís Bianchi; Manel Solé; Juan Ramón Ayuso; Loreto Boix; Margarita Sala; María Varela; Josep M Llovet; Concepció Brú; Jordi Bruix
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

10.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

View more
  5 in total

Review 1.  Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

Authors:  Tin Nadarevic; Vanja Giljaca; Agostino Colli; Mirella Fraquelli; Giovanni Casazza; Damir Miletic; Davor Štimac
Journal:  Cochrane Database Syst Rev       Date:  2021-10-06

Review 2.  Spectral detector CT applications in advanced liver imaging.

Authors:  Noor Fatima Majeed; Marta Braschi Amirfarzan; Christoph Wald; Jeremy R Wortman
Journal:  Br J Radiol       Date:  2021-05-28       Impact factor: 3.629

3.  Virtual monoenergetic images from spectral detector computed tomography facilitate washout assessment in arterially hyper-enhancing liver lesions.

Authors:  R P Reimer; N Große Hokamp; A Fehrmann Efferoth; A Krauskopf; D Zopfs; J R Kröger; T Persigehl; D Maintz; A C Bunck
Journal:  Eur Radiol       Date:  2020-11-12       Impact factor: 5.315

4.  Material decomposition using iodine quantification on spectral CT for characterising nodules in the cirrhotic liver: a retrospective study.

Authors:  Shalini Thapar Laroia; Komal Yadav; Senthil Kumar; Archana Rastogi; Guresh Kumar; Shiv Kumar Sarin
Journal:  Eur Radiol Exp       Date:  2021-05-28

5.  Differentiation of Hepatocellular Carcinoma from Hepatic Hemangioma and Focal Nodular Hyperplasia using Computed Tomographic Spectral Imaging.

Authors:  Weixia Li; Ruokun Li; Xiangtian Zhao; Xiaozhu Lin; Yixing Yu; Jing Zhang; Kemin Chen; Weimin Chai; Fuhua Yan
Journal:  J Clin Transl Hepatol       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.